Analysts Issue Forecasts for KROS Q1 Earnings
Keros Therapeutics, Inc. (NASDAQ:KROS – Free Report) – Equities research analysts at William Blair issued their Q1 2026 earnings per share (EPS) estimates for shares of Keros Therapeutics in a report released on Thursday, February 27th. William Blair analyst M. Phipps expects that the company will post earnings of ($0.61) per share for the quarter. […]
Keros Therapeutics, Inc. (NASDAQ:KROS – Free Report) – Equities research analysts at William Blair issued their Q1 2026 earnings per share (EPS) estimates for shares of Keros Therapeutics in a report released on Thursday, February 27th. William Blair analyst M. Phipps expects that the company will post earnings of ($0.61) per share for the quarter. […]
